Literature DB >> 24311766

6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.

Roland M du Bois1, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Jonathan A Leff, Paul W Noble, Steven A Sahn, Dominique Valeyre, Derek Weycker, Talmadge E King.   

Abstract

6-min walk distance (6MWD) has recently been shown to be associated with the risk of mortality in patients with idiopathic pulmonary fibrosis (IPF); however, the independent contribution of 6MWD to the prediction of mortality risk has not been evaluated in a large, well-defined population of patients with IPF. A Cox proportional hazards model was used to characterise the relationship between risk factors of interest and all-cause mortality in IPF patients who completed a week 24 study visit in a clinical trial evaluating interferon γ-1b (n=748). Risk factors of interest included the independent predictors of mortality in the previously published clinical prediction model together with 6MWD and 24-week change in 6MWD. Baseline 6MWD <250 m was associated with a two-fold increase in the risk of mortality (hazard ratio 2.12, 95% CI 1.15-3.92) and a 24-week decline in 6MWD >50 m was associated with a nearly three-fold increase in mortality risk (hazard ratio 2.73; 95% CI 1.60-4.66). Inclusion of 6MWD data improved model discrimination compared with the original model (C-statistic 0.80 (95% CI 0.76-0.85) versus 0.75 (0.71-0.79)). Both 6MWD and change in 6MWD are independent predictors of mortality in patients with IPF. The addition of 6MWD to the clinical prediction model improves model discrimination compared with the original model.

Entities:  

Mesh:

Year:  2013        PMID: 24311766     DOI: 10.1183/09031936.00131813

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  54 in total

Review 1.  Current best practice in rehabilitation in interstitial lung disease.

Authors:  Atsuhito Nakazawa; Narelle S Cox; Anne E Holland
Journal:  Ther Adv Respir Dis       Date:  2016-11-15       Impact factor: 4.031

2.  Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.

Authors:  Julie Morisset; Eric Vittinghoff; Brett M Elicker; Xiaowen Hu; Stephanie Le; Jay H Ryu; Kirk D Jones; Anna Haemel; Jeffrey A Golden; Francesco Boin; Brett Ley; Paul J Wolters; Talmadge E King; Harold R Collard; Joyce S Lee
Journal:  Chest       Date:  2017-06-16       Impact factor: 9.410

3.  Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?

Authors:  Karishma Hosein; Jamie Le; Marco Mura
Journal:  Lung       Date:  2016-11-17       Impact factor: 2.584

Review 4.  Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.

Authors:  Priya Agarwala; Steve H Salzman
Journal:  Chest       Date:  2019-11-02       Impact factor: 9.410

5.  The CALIPER-Revised Version of the Composite Physiologic Index is a Better Predictor of Survival in IPF than the Original Version.

Authors:  Karishma S Hosein; Gianluigi Sergiacomi; Maurizio Zompatori; Marco Mura
Journal:  Lung       Date:  2019-12-02       Impact factor: 2.584

6.  Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.

Authors:  Ganesh Raghu; Bernt van den Blink; Mark J Hamblin; A Whitney Brown; Jeffrey A Golden; Lawrence A Ho; Marlies S Wijsenbeek; Martina Vasakova; Alberto Pesci; Danielle E Antin-Ozerkis; Keith C Meyer; Michael Kreuter; Hugues Santin-Janin; Geert-Jan Mulder; Brian Bartholmai; Renu Gupta; Luca Richeldi
Journal:  JAMA       Date:  2018-06-12       Impact factor: 56.272

7.  Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.

Authors:  Hana Serajeddini; Paola Rogliani; Marco Mura
Journal:  Lung       Date:  2018-08-27       Impact factor: 2.584

8.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

9.  Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?

Authors:  Kamonpun Ussavarungsi; Augustine S Lee; Charles D Burger
Journal:  Oman Med J       Date:  2016-09

10.  Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience.

Authors:  David Bennett; Antonella Fossi; Elena Bargagli; Rosa Metella Refini; Maria Pieroni; Luca Luzzi; Claudia Ghiribelli; Piero Paladini; Luca Voltolini; Paola Rottoli
Journal:  Lung       Date:  2015-07-28       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.